Skip to main content
. 2024 Dec 9;52:102198. doi: 10.1016/j.tranon.2024.102198

Fig. 2.

Fig. 2

Relationship between perioperative change of circulating lymphocyte subsets with varying immunophenotypes and recurrence-free survival (RFS)/progression‐free survival (PFS) in the entire group. (A) RFS/PFS for NKA recovery on POD30 in the entire group. (B) RFS/PFS for NKA recovery on POD30 in the stage III/IV group. (C) RFS/PFS for postoperative increment of percentage of CD56bright NK cell on POD30 in the entire group. (D) RFS/PFS for postoperative increment of percentage of CD56 dim_ CD16+ NK cell on POD30 in the entire group. (E) RFS/PFS for postoperative circulating CD56bright NK cell/CD56dim NK cell ratio in the entire group. (F) RFS/PFS for postoperative circulating CD56bright_CD16 NK cell/CD56 dim_ CD16+ cell ratio in the entire group.